Biology
Randomised controlled trials for mpox in endemic countries
K. Uriu, J. Ito, et al.
Discover the groundbreaking findings on the SARS-CoV-2 Omicron XBB.1.5 variant, which showcases significantly enhanced ACE2 receptor binding and remarkable resistance to neutralizing antibodies. Conducted by a team of esteemed researchers from various institutions, this study sheds light on the variant's rapid global spread and its ability to evade immune responses.
Related Publications
Explore these studies to deepen your understanding of the subject.

